Resche-Rigon M - Search Results

1

Using the continual reassessment method to estimate the minimum effective dose in phase II dose-finding studies: a case study.

Zohar S, Resche-Rigon M, Chevret S. Zohar S, et al. Clin Trials. 2013;10(3):414-21. doi: 10.1177/1740774511411593. Epub 2011 Aug 8. Clin Trials. 2013. PMID: 21824977

2

Local influence for the subdistribution of a competing risk.

Resche-Rigon M, Chevret S. Resche-Rigon M, et al. Stat Med. 2006 Jun 15;25(11):1937-47. doi: 10.1002/sim.2354. Stat Med. 2006. PMID: 16158402

3

Evaluating mortality in intensive care units: contribution of competing risks analyses.

Resche-Rigon M, Azoulay E, Chevret S. Resche-Rigon M, et al. Crit Care. 2006 Feb;10(1):R5. doi: 10.1186/cc3921. Crit Care. 2006. PMID: 16356211 Free PMC article.

4

Analysing multicentre competing risks data with a mixed proportional hazards model for the subdistribution.

Katsahian S, Resche-Rigon M, Chevret S, Porcher R. Katsahian S, et al. Stat Med. 2006 Dec 30;25(24):4267-78. doi: 10.1002/sim.2684. Stat Med. 2006. PMID: 16960919

5

Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes.

Resche-Rigon M, Zohar S, Chevret S. Resche-Rigon M, et al. Clin Trials. 2008;5(6):595-606. doi: 10.1177/1740774508098788. Clin Trials. 2008. PMID: 19029208

6

Dose-finding design driven by efficacy in onco-hematology phase I/II trials.

Seegers V, Chevret S, Resche-Rigon M. Seegers V, et al. Stat Med. 2011 Jun 15;30(13):1574-83. doi: 10.1002/sim.4152. Epub 2011 Mar 11. Stat Med. 2011. PMID: 21394754

7

Evaluation of the propensity score methods for estimating marginal odds ratios in case of small sample size.

Pirracchio R, Resche-Rigon M, Chevret S. Pirracchio R, et al. BMC Med Res Methodol. 2012 May 30;12:70. doi: 10.1186/1471-2288-12-70. BMC Med Res Methodol. 2012. PMID: 22646911 Free PMC article.

8

Surgery for caustic injuries of the upper gastrointestinal tract.

Chirica M, Resche-Rigon M, Bongrand NM, Zohar S, Halimi B, Gornet JM, Sarfati E, Cattan P. Chirica M, et al. Ann Surg. 2012 Dec;256(6):994-1001. doi: 10.1097/SLA.0b013e3182583fb2. Ann Surg. 2012. PMID: 22824850

9

Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.

Resche-Rigon M, Pirracchio R, Robin M, De Latour RP, Sibon D, Ades L, Ribaud P, Fermand JP, Thieblemont C, Socié G, Chevret S. Resche-Rigon M, et al. BMC Blood Disord. 2012 Aug 16;12:10. doi: 10.1186/1471-2326-12-10. BMC Blood Disord. 2012. PMID: 22898556 Free PMC article.

10

Continuous positive airway pressure (CPAP) may not reduce short-term mortality in cardiogenic pulmonary edema: a propensity-based analysis.

Pirracchio R, Resche Rigon M, Mebazaa A, Zannad F, Alla F, Chevret S. Pirracchio R, et al. J Card Fail. 2013 Feb;19(2):108-16. doi: 10.1016/j.cardfail.2012.12.006. J Card Fail. 2013. PMID: 23384636

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

260 results

Search Page

Filters